ESC Premium Access

Opportunities for clinician education in the pharmacotherapy of stable heart failure

Congress Session

About the speaker

Doctor Peter Conor Murray

St. James's Hospital, Dublin (Ireland)
0 follower

218 more presentations in this session

Intermittent therapy with levosimendan in patients with advanced heart failure

Speaker: Professor M. Weis (Munich, DE)

Thumbnail

Differences in long-term all-cause and cardiovascular mortality according to heart failure aetiology in ambulatory patients

Speaker: Doctor G. Spitaleri (Badalona, ES)

Thumbnail

Comparing the central arterial stiffness indices in the decompensated and compensated states of heart failure: a cohort study

Speaker: Assistant Professor G. Youssef (Cairo, EG)

Thumbnail

Systolic blood pressure visit-to-visit variability and clinical outcomes of heart failure with preserved ejection fraction

Speaker: Doctor Q. Zhang (Tianjin, CN)

Thumbnail

The risks and benefits of spironolactone use in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease

Speaker: Mrs O. Obertynska (Vinnitsa, UA)

Thumbnail

Access the full session

Chronic heart failure e-posters

Speakers: Doctor P. Murray, Professor M. Weis, Doctor G. Spitaleri, Assistant Professor G. Youssef, Doctor Q. Zhang...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Live panel discussion.

27 August 2021

ESC Premium Access

Current use of NT-proBNP in elderly patients and the impact of the selected threshold value: lessons from a big data analysis

27 August 2021

ESC Premium Access

Effects of Sacubitril/valsartan compared with ramipril on coronary events after myocardial infarction - Results from the PARADISE-MI Trial

27 August 2021

This platform is supported by

logo Novo Nordisk